Evidence map›Paper›PMID 31455221›Full record

ArticleBMC plant biology2019

Integrating molecular characterization and metabolites profile revealed CtCHI1's significant role in Carthamus tinctorius L.

Dandan Guo, Yue Gao, Fei Liu, Beixuan He, Xinlei Jia, Fanwang Meng, Hai Zhang, Meili Guo

Open access · goldAbstract read
In one paragraph

Article in BMC plant biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Both TwoFrontiers in plant science · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Dandan GuoPharmacy college, Second Military Medical University, Shanghai, China.
Yue GaoPharmacy college, Second Military Medical University, Shanghai, China.
Fei LiuPharmacy college, Second Military Medical University, Shanghai, China.
Beixuan HePharmacy college, Second Military Medical University, Shanghai, China.
Xinlei JiaPharmacy college, Second Military Medical University, Shanghai, China.
Fanwang MengDepartment of Chemistry, Shanghai University, Shanghai, China.
Hai ZhangDepartment of Pharmacy, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China. zhxdks2005@126.com.
Meili GuoPharmacy college, Second Military Medical University, Shanghai, China. mlguo2014@126.com.ORCID http://orcid.org/0000-0003-4858-1396
Second Military Medical University · CNShanghai First Maternity and Infant Hospital · CNShanghai University · CN

Funding

"863" High Technology Project 2008AA02Z137Natural Science Foundation of China 81173484Natural Science Foundation of China 81473300Shanghai Natural Science Foundation 13ZR1448200
6 · The paper itself

Abstract

backgroundAs a traditional Chinese herb, safflower (Carthamus tinctorius L.) is valued for its florets to prevent cardiovascular and cerebrovascular diseases. Basing on previous chemical analysis, the main active compounds are flavonoids in its florets. Although flavonoid biosynthetic pathway has been well-documented in many model species, unique biosynthetic pathway remains to be explored in safflower. Of note, as an important class of transitional enzymes, chalcone isomerase (CHI) has not been characterized in safflower.

resultsAccording to our previous research, CHIs were identified in a safflower transcriptome library built by our lab. To characterize CHI in safflower, a CHI gene named CtCHI1 was identified. A multiple sequences alignment and phylogenetic tree demonstrate that CtCHI1 shares 92% amino acid identity and close relationship with CHI to Saussurea medusa. Additionally, subcellular localization analysis indicated CtCHI1-GFP fusion protein was mainly in the cell nucleus. Further, we purified CtCHI1 protein from E. coli which can effectively catalyze isomerization of 2',4',4,6'-tetrahydroxychalcone into naringenin in vitro. Via genetic engineer technology, we successfully obtained transgenic tobacco and safflower lines. In transgenic tobacco, overexpression of CtCHI1 significantly inhibited main secondary metabolites accumulation, including quercetin (~ 79.63% for ovx-5 line) and anthocyanins (~ 64.55% for ovx-15 line). As shown in transgenic safflower, overexpression of CtCHI1 resulted in upstream genes CtPAL3 and CtC4H1 increasing dramatically (up to ~ 3.9fold) while Ct4CL3, CtF3H and CtDFR2 were inhibited. Also, comparing the whole metabolomics database by PCA and PLS-DA between transgenic and control group, 788 potential differential metabolites were marked and most of them displayed up-regulated trends. In parallel, some isolated secondary metabolites, such as hydroxysafflor yellow A (HSYA), rutin, kaempferol-3-O-β-rutinoside and dihydrokaempferol, accumulated in transgenic safflower plants.

conclusionsIn this study, we found that CtCHI1 is an active, functional, catalytic protein. Moreover, CtCHI1 can negatively and competitively regulate anthocyanins and quercetin pathway branches in tobacco. By contrast, CtCHI1 can positively regulate flavonol and chalcone metabolic flow in safflower. This research provides some clues to understand CHI's differential biochemical functional characterization involving in flavonoid pathway. More molecular mechanisms of CHI remain to be explored in the near future.

Indexed as

Amino Acid SequenceBiosynthetic PathwaysCarthamus tinctoriusIntramolecular LyasesPhylogenyPlant ProteinsSecondary MetabolismSequence Alignmentchalcone isomeraseIntramolecular LyasesPlant ProteinsCarthamus tinctorius L.Chalcone isomeraseFlavonoid biosynthesisMetabolic databaseModel plant

Identifiers

PMID31455221
PMCPMC6712624
OpenAlexW2971073238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.